Gastroenterology may be on the verge of shifting from episodic, flare-driven care to continuous, AI-enabled chronic disease management. According to GI leaders interviewed by Becker’s, AI-powered remote monitoring—particularly in inflammatory bowel disease (IBD)—could use patient-reported symptoms and biomarker data (e.g., fecal calprotectin) to predict flares, guide treatment escalation, and prioritize care in real time.
Keep Reading
Add A Comment